Http://bit.ly/PC_SEP_2017_ATTENDEES.

Slides:

Advertisements

Similar presentations

Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)

Advertisements

Participation Requirements for a Patient Representative.

HIT Standards Committee Clinical Operations Workgroup Report Jamie Ferguson, Chair Kaiser Permanente John Halamka, Co-chair Harvard Medical School 21 July,

The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.

TACKLING REGULATORY CREEP Some observations from food regulation Michael Hunt Food & Drink Federation.

Pharmacoeconomics Research Unit RESEARCH. DECISION SUPPORT. KNOWLEDGE TRANSLATION. CAPACITY BUILDING. Assessment of the pan-Canadian Oncology Drug Review.

Continued discussion on Section I: Best Available Vocabulary/Code Set/Terminology Standards and Implementation Specifications 2015 Interoperability Standards.

Quality Improvements Based on Detailed and Precise Terminology EFMI on Iceland June 2010 Kirsten Bredegaard, Senior Manager Connected Digital Health in.

Preventive Ethics Beyond the Basics. Module 2 Prioritizing Among Ethics Issues.

HIT Standards Committee Clinical Operations Workgroup Report Jamie Ferguson, Chair Kaiser Permanente John Halamka, Co-chair Harvard Medical School 20 August,

HIT Policy Committee Clinical Operations Workgroup Report Jamie Ferguson Kaiser Permanente John Halamka Harvard Medical School 16 July, 2009.

Mandatory Payload = MU2 Consolidated CDA. Qualifier: "leniency" (allowance for null or alternative codes) should be allowed in the following areas of structured.

Recommendation 2001/331/EC: Review and relation to sectoral inspection requirements Miroslav Angelov European Commission DG Environment, Unit A 1 Enforcement,

1 Incorporating Data Mining Applications into Clinical Guidelines Reza Sherafat Dr. Kamran Sartipi Department of Computing and Software McMaster University,

Care Packages in Substance Misuse Treatment Development of MH Care Clusters: overview  Service users in MH, clinicians found: idiosyncratic referral pathways.

HIT Standards Committee Clinical Operations Workgroup, Vocabulary Task Force Update on Vocabulary For Stage 2 Jamie Ferguson, Kaiser Permanente Betsy Humphreys,

HIT Standards Committee Clinical Operations Workgroup Jamie Ferguson Kaiser Permanente John Halamka Harvard University February 24, 2010.

Drug Information Services Systematic approach to answering drug information requests.

FDA Public Meeting Electronic Records; Electronic Signatures Docket No. 2004N-0133 Madeleine Kennedy & Michael Rutherford Eli Lilly and Company 11 June.

TITLE OF AUDIT Author Date of presentation. Background Why did you do the audit? e.g. high risk / high cost / frequent procedure? Concern that best practice.

Could it happen here Campaign Patient died of Clostridium difficile.

Dispelling the myths about dm+d Presenter: Karen ReesDate: 10 th December 2014 dm+d and the NHS Standard.

1 The information contained in this presentation is based on proposed and working documents. Health Information Exchange Interoperability Minnesota Department.

Understanding Health Economics Nicola Cooper, PhD Professor of Healthcare Evaluation Research Department of Health Sciences University of Leicester

FIT Programme (Faecal Immunohistochemical Test)

Biostatistics Case Studies 2007

Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program

STATE HEALTH INFORMATION GUIDANCE

ECVCP Recommendations On Reference Values 2008

The Way Forward Questions Options.

NURS3030H NURSING RESEARCH IN PRACTICE MODULE 7 ‘Systematic Reviews’’

CCHIT Roadmap Discussion Items

Stephen Joseph Galli, MD Journal of Allergy and Clinical Immunology

NeurOn: Modeling Ontology for Neurosurgery

6-Building Block Workshop

Scope The scope of this test is to make a preliminary assessment of the fitness of the Draft Observables and Investigation Model (Observables model)

Selecting Allergen for BAT

How to read a paper D. Singh-Ranger.

Overview of Request for Comments ONC 2017 Interoperability Standards Advisory ONC looking for comments on any last revisions, additions, or recommendations.

Drug and Substance Project Update

Poster Title Goes Here. Make It Attractive To Your Audience.

Drug and Substance Project Update

Drug Allergy Substance List

Sample Size Estimation

ESM of Biomedical and Infectious Wastes Under the Basel Convention

Random error, Confidence intervals and P-values

CDC Guidelines for Use of QuantiFERON®-TB Gold Test

22nd February 2012 Mars Incorporated

Informed Consent to Treatment

Differentiating Drug-Seeking Behavior From Poorly Controlled Pain

**This may be expedited depending on PRMC SOP

Health Information Exchange Interoperability

Results of the Survey on Mining and Quarrying Waste Statistics

What defines an international statistical standard and other types of international statistical publications in economic statistics? Second Meeting of.

Issues in Hypothesis Testing in the Context of Extrapolation

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Approaches to Implementing in Your Organization

Brief Interview & Referral for Opioid Use Disorder Script

By Alan I. Kaplan, Attorney at Law

Allergy Intolerance Resource – Model Meaning

National Credentialing Forum 2019 San Diego, CA February

Goal Objectives Expected Outcomes

Single Pivotal vs Two Replicated Studies. Zijiang Yang

Report Writing Unit III.

Regulatory Perspective of the Use of EHRs in RCTs

Results of the AEG e-discussion on Reverse transactions

Adverse Event Analysis

Rachel Wiseman1, MPH; David G

Evidence Based Diagnosis

Regulatory-Industry Statistics Workshop , 2019

Presentation transcript:

http://bit.ly/PC_SEP_2017_ATTENDEES

Most Negatives Persuasive; PC to clarify document: 10, 11, 14, 16, 17, 21, 40, 42, 43, 50, 51, 55, 60, 71 Need clarification from submitter: 2, 5, 9, 12, 18, 19, 20, 44, 54 (i.e., we may agree, but need to clarify what is being proposed)

Questions Cutoff: Vaccines Synonymy (86) Not recommended. 62: 99% sounds ok 93: What’s listed here Meds vs Foods Pick a statistically defensible target. Vaccines Mostly questions, not answers Will consult CDC. 63: RxNorm best for use case Synonymy (86) Not recommended. Guidance: include or not Yes, include, with guidance. Class definitions Open, but probably stay the course.

Cross-reactive class definition Cerner supports the recommendations of SNOMED CT for food and environmental allergens, and RxNorm for substances (IN) and mixtures (MIN). We also accept the adoption of SNOMED CT (substance hierarchy) as the interim choice for allergen drug classes due to its broad international reach; however, we consider the use of NDF-RT/MED-RT to be acceptable as well because of its historical support and existing use among many stakeholders. We agree with the considerations outlined in Section 3, and supports the Patient Care Work Group continuing to review other choices (e.g., G-SRS, IDMP) as they become available. If an allergy class does not specifically identify the constituent members, it is subject to individual and inconsistent interpretation. For example, in one system, the opioid analgesic class may have propoxyphene as a member, whereas another system may include propoxyphene in the methadone derivatives class. Sharing allergy information between these systems would result in a false negative warning in the receiving system if propoxyphene is prescribed, and a false positive warning for hydrocodone. Information sharing is increased, but the quality and ultimate utility of the shared information poses a risk to the patient, and artificially reduces the available treatment choices. Allergy classes can be broadly identified as structural (e.g., sulfonamides), functional (e.g., NSAIDS), and structural + functional (sulfonamide antibiotics). For example, celecoxib may be placed in both the sulfonamide and NSAID classes. How this is handled within each system, and how the clinical decision support functions may vary.